NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

That's actually something that you implied in your post about high Cognate costs and LP "saving" nwbo.

How many years since any new patients? Suffice it to say that costs the last few years are not about cell manufacturing or producing vaccine. Must be the cost to reserve space (and some Advent setup costs).

From 2017 to 2018, Cognate expenses dropped from over 14m (combined Cognate US, Germany, Israel) to around 1m. Over the same two years, Advent ramped up from $1.8m to 6.2m.

https://www.sec.gov/Archives/edgar/data/1072379/000114420419017803/tv517288_10k.htm